单纯疱疹病毒1型单链结合蛋白ICP8研究进展

在单纯疱疹病毒1型(Herpes simplex virus 1,HSV⁃1)中,感染细胞蛋白8(Infected cell protein 8,ICP8)是由UL29基因编码的一种单链DNA结合蛋白(Single strand DNA⁃binding protein,SSBP),该蛋白在病毒复制中必不可缺,具有维持单链DNA的稳定性,并与其他病毒蛋白相互结合,促进病毒复制室的形成,介导晚期基因的表达。除此之外,ICP8还具有促进UL9编码的起源结合蛋白(Origin binding protein,OBP)和UL5/UL8/UL52蛋白的酶活性,与UL12蛋白共同介导链交换等功能。本文就上述目前国内外对HSV⁃1 ICP8的研究进展作一综述,以期为后续研究ICP8的作用机制提供参考。     

单纯疱疹病毒Ⅰ型免疫逃避机制——ICP47抑制抗原加工相关转运蛋白

病毒侵入宿主后的感染过程除导致相应的病理学结果外,还能引发机体非特异性、特异性抗病毒免疫反应清除病原体。在特异性免疫反应中,机体能否对“异已”抗原进行有效识别,在很大程度上是通过抗原呈递细胞实现的。抗原呈递细胞APC(包括树突状细胞DC、巨噬细胞、B细胞等)能捕捉、     

单纯疱疹病毒2型感染细胞多肽27真核表达质粒的构建及表达

为了构建单纯疱疹病毒2型(HSV-2)感染细胞多肽27(ICP27)真核表达质粒,应用PCR技术从HSV-2 333株的基因组中扩增ICP27基因,并连接至真核表达载体pEGFPC2,对阳性克隆进行菌落PCR、酶切和测序鉴定后,成功构建了重组质粒pEGFPC2-ICP27。用X fect转染试剂盒将重组质粒pEGFPC2-ICP27转染至Vero细胞中,并用RT-PCR及W estern b lot-ting检测其表达情况。结果显示,ICP27基因在Vero细胞中得到正确表达。真核表达质粒pEGFPC2-ICP27的构建成功,为进一步研究ICP27对宿主细胞的影响奠定了基础。     

戊型肝炎病毒IV型衣壳蛋白缺失突变体原核表达与性质

采用PCR技术扩增基因IV型HEV(Hepatitis E Virus,HEV)开放阅读框2(Open Reading Frame 2,ORF2)的缺失突变体(aa384-606),亚克隆到表达载体后,转化到大肠杆菌中进行诱导表达,表达蛋白命名为rP24。SDS-PAGE和免疫印迹实验表明,rP24获得了高效表达,且和单克隆抗体15B2具有强的反应活性。rP24经过包涵体洗涤、溶解复性、离子交换层析和分子筛层析纯化后,免疫印迹实验表明,纯化rP24能与抗HEV ORF2中和单克隆抗体8C11以及HE(Hepatitis E,HE)阳性血清发生很强的免疫反应性,说明rP24上具有构象型中和表位,模拟了HEV衣壳蛋白的空间结构。动态光散色测量结果表明,rP24的平均水化半径为7.48 nm;纯化rP24免疫动物实验表明,rP24具有强的抗原性,小鼠阳转周期短,抗体持续时间长;纯化rP24作为包被抗原检测HE阳性血清和阴性血清,结果显示rP24对HE阳性血清和阴性血清检出率与北京万泰公司的抗HEV-IgG检测试剂盒的检出率一致。这些实验结果说明,具有较好免疫反应性和免疫原性的rP24获得了高效表达,该蛋白模拟了天然病毒衣壳蛋白的中和表位,为进一步研究基因I型和基因IV型HEV感染不同宿主细胞差异的分子机制奠定了基础。     

2型单纯疱疹病毒毒力蛋白ICP34.5的真核表达及其对Ve-ro细胞活性的影响

目的:在非洲绿猴肾细胞(Vero细胞)中表达2型单纯疱疹病毒(HSV-2)毒力蛋白感染细胞多肽34.5(ICP34.5),并检测其对Vero细胞活性的影响。方法:PCR扩增HSV-2的ICP34.5基因,连接至pEGFP-C2载体,并对重组真核表达载体pEGFP-ICP34.5进行双酶切测序验证;将重组子瞬时转染Vero细胞,RT-PCR检测其在mRNA水平的表达,荧光倒置显微镜观察融合蛋白的表达,MTT法检测细胞活性。结果:经双酶切和测序验证表明pEGFP-ICP34.5构建成功,转染细胞后经RT-PCR验证有目的基因的转录,荧光显微镜下观察到融合蛋白在转染的Vero细胞中表达,MTT法检测结果证实重组质粒可以抵消空质粒对细胞的损伤作用。结论:构建了pEGFP-ICP34.5真核表达载体,其能在Vero细胞中高效表达,并能抵消空质粒对细胞的损伤作用。     

MBP-gldABC融合蛋白基因的原核表达载体的构建

目的：构建可高效生产甘油脱水酶的大肠杆菌工程菌,方法：将编码甘油脱水酶的三个基因gldA、gldB、gldC,分别克隆至克隆载体pMD18-T和pSIM-T中,经测序正确后,再亚克隆至表达融合蛋白的高效表达载体pMAL-c2X上,构建成表达质粒pMAL-gldABC,并转化大肠杆菌E.coli DH5α。结果：成功地将甘油脱水酶基因gldABC以同向串联方式克隆到大肠杆菌融合表达载体pMAL-c2X中,结论：得到了含gldABC基因的MBP融合蛋白表达载体,为研究甘油脱水酶基因（gldABC）的在原核表达载体中的串联表达奠定了基础。     

单纯疱疹病毒I型扩增子系列载体的构建

我们先前已报道了构建成一种能在ＨＳＶ ｔｓＫ株辅助下进行复制和包装,并表达β－半乳糖苷酶基因ｌａｃＺ的ＨＳＶ－１扩增子质粒ｐＨＳＬ,以及它的应用。该质料中依次含有ＨＳＶ－１复制起点ｏｒｉＳ序列及ＩＥ６８启动子、ｌａｃＺ基因、ＳＶ４０ｐｏｌｙＡ、ＨＳＶ－１包装信号‘ａ’序列和大肠杆菌质粒骨架。然而,该质粒中的报告基因ｌａｃＺ无法用简单的酶切方法卸载下来,继而装入目的基因。本研究在此基础上,新构建了一     

单纯疱疹病毒特异性糖蛋白抗原的原核表达及纯化

原核表达并纯化单纯疱疹病毒特异性糖蛋白抗原,用于建立单纯疱疹病毒的临床检测方法。选择单纯疱疹病毒特异性糖蛋白型共同抗原gD以及型特异性抗原gGl(Ⅰ型)、gG2(Ⅱ型),合成PCR引物,分别扩增其DNA片段,插入原核表达载体pQE30,转化大肠杆菌M15,筛选高表达菌株,进行初步纯化鉴定。结果获得了表达菌株,对高表达的gD初步进行了包涵体的复性及纯化,为建立单纯疱疹病毒临床检测方法奠定了基础。     

SARS冠状病毒核衣壳(N)蛋白不同区域的原核表达

利用大肠杆菌表达系统对SARS冠状病毒的核衣壳(N)蛋白全长及N末端或／和C末端缺失突变体进行了表达,共表达了39个重组蛋白,表达量在15％～30％之间。分别利用电洗脱或金属鳌合介质纯化重组蛋白,用蛋白印迹实验检测纯化蛋白对SARS病人恢复期血清的反应性,结果发现全长N蛋白活性最好,其余的末端缺失蛋白均无法达到同—：活性水平。由此说明N蛋白的完整性对于其优势表位的充分暴露是必要的。     

单纯疱疹病毒I型扩增子质粒载体的构建及LacZ基因的表达

从单纯疱疹病毒Ｉ型ＨＳＶ－１基因组中分离出其包装信号序列,与含ＨＳＶ－１复制起点及ＩＥ－６８基因启动子的ＤＮＡ序列、β半乳糖苷酶基因和大肠杆菌质粒骨架,构建了一种ＨＳＶ－１扩增子质粒载体ｐＨＳＬ,其中ＬａｃＺ基因置于ＩＥ－６８基因启动子控制下。将此质粒转染已感染了ＨＳＶ－１温度敏感株ｔｓＫ株的Ｖｅｒｏ细胞,ｐＨＳＬ可在ＨＳＶ－１ｔｓＫ的辅助下包装成假病毒颗粒,这样就可得到同时含有假病毒和ＨＳＶ－１     

单纯疱疹病毒2型疫苗的研究进展

单纯疱疹病毒2型(herpes simplex virus type 2,HSV-2)是人类疱疹病毒家族中α家族成员,可引起多年龄段的人群生殖器疱疹及其他疱疹疾病。由于该病毒具有复杂的基因结构及感染病理,其感染至今尚无有效的治疗方法。该病毒可抑制机体免疫系统,在神经细胞潜伏感染,具有重激活特性,因此,其疫苗的研制亦需要复杂的技术,且面临重重的挑战。     

Herpes Simplex Virus Type 1 ICP27 Protein： Its Expression, Purification and Specific Antiserum Production

Herpes simplex virus type 1 (HSV-1) is the causative agent of cold sores and other more serious diseases. HSV-1 infected-cell protein 27 (ICP27) is an immediate-early regulatory phosphoprotein homologous to gene products identified in all classes of herpesviruses so far. To raise the antiserum to ICP27 for further characterization of its biological function, the ICP27 gene was cloned into the pET-28a (+) vector, then ICP27 protein was expressed in E. Coli and purified by nickel-nitrilotriacetic acid (Ni2+-NTA) affinity resin column,finally the purified protein was used to raise antiserum. Western blot analysis demonstrated that the antiserum recognized the recombinant protein, and the antiserum was able to probe the ICP27 in HSV-1 infected cells with high specificity by immunofluorescence assay (IFA). Therefore, the specific antiserum will provide a valuable tool for further studies investigating ICP27's biological function during HSV-1 infection.     

Intercellular trafficking of herpes simplex virus type 2 UL14 deletion mutant proteins

The UL14 gene product of herpes simplex virus is a 32kDa protein expressed late in infection and is a minor component of the virion tegument. We recently showed that the wild-type UL14 protein has heat shock protein (HSP)-like and/or molecular chaperone-like functions. In this study, the intracellular localization of UL14 wild-type and deletion mutant proteins was examined in transfected cells by immunofluorescence. We found that N-terminus deleted but not wild-type/C-terminus deleted mutant proteins showed a significant number of cytoplasmic, multi-cellular stains in transfected Vero cells. The effect was greatly intensified by subjecting cells to heat shock at 43 degrees C, whereas it was obstructed by treatment with the microfilament-disrupting drug cytochalasin D. The staining patterns of UL14 antigen-positive cells after heat shock suggested a cell-to-cell spread of the protein. Although the mechanism is unclear, the phenomenon seems to be an unprecedented type of intercellular trafficking.     

Expression of HSV-1 ICP0 antigen peptide in prokaryotic cells and preparation of specific antibody

As an immediate-early protein of herpes simplex virus, infected-cell polypeptide 0 (ICP0) exhibits complicated interactions with host cells, and its regulatory function on gene expression is of great importance. Since the ICP0 encoding sequence contains many rare codons which are absent in E.coli, and ICP0 is highly unstable in prokaryotic cells, expression of entire ICP0 in prokaryotic cells has never been reported. In order to further investigate the function of ICP0, a recombinant plasmid was constructed by subcloning a cDNA fragment encoding an amino-terminal of 105 residues of the ICP0 protein into pGEX-5x-1 vector. The resulting GST-105 fusion antigen peptide was expressed with high efficiency in E.coli. Antibodies prepared after the immunization of mice with purified fusion protein can recognize not only the denatured ICP0 protein, but also the native ICP0 protein with normal biological conformation. Foundation items: National natural science foundation items (30570081 and 30670094)     

单纯疱疹病毒II型糖蛋白G主要抗原表位的表达和抗原性检测*

利用PCR拼接技术,合成含单纯疱疹病毒II型糖蛋白G(gG2)抗原表位（氨基酸序列第561～578位）的片段,并进一步利用基因工程技术获得该表位的双拷贝片段,克隆入pET-KDO表达载体进行原核表达。经IPTG诱导后,高效表达出分子量大小约为39,000D的融合蛋白,经Western-blot检测具有良好的抗原性。表达的融合蛋白经凝血酶切割和亲和层析纯化,得到双拷贝gG2（561～578aa）目的蛋白,经ELISA检测具有良好的灵敏度和特异性。该重组抗原的构建和表达可用于HSV-2特异性血清学诊断的研究。     

重组hKGF2原核表达载体的构建及其蛋白质的纯化

角质细胞生长因子2（ keratinocyte growth factor 2, KGF2）是新近发现且发展迅速的成纤维细胞生长因子家族中新的一员,又称FGF10,是上皮细胞特异性的促有丝分裂剂,应用前景广泛。为构建其高效原核表达菌株,首先用RT-PCR法从培养的人胚胎肺成纤维细胞中获得去除信号肽的hKGF2 cDNA,将其插入pMD18-T载体;经测序后,克隆入pET-30a( + )表达载体,将成功构建的pET-30a( + )- hKGF2重组表达载体转入大肠杆菌BL21（DE3）,经IPTG诱导表达后, SDS-PAGE及Western blot鉴定重组蛋白为高效可溶性表达。重组蛋白经Ni+-NTA（镍亲和层析）一步法纯化后纯度达95%以上,为进一步的应用研究及大规模生产奠定了基础。     

Glycosaminoglycans are not indispensable for the anti-herpes simplex virus type 2 activity of lactoferrin

Lactoferrin has been recognized as a potent inhibitor of human herpetic viruses, such as herpes simplex type 1 (HSV-1) and 2 (HSV-2). In particular, bovine lactoferrin (bLf) has been found to prevent viral infection by binding to heparan sulphate (HS) glycosaminoglycans (GAGs) that in turn can act as cell receptors for human herpetic viruses. In this study we further investigate the mechanism of inhibiting activity of both human lactoferrin (hLf) and bLf against HSV-2. The antiviral effect of these proteins towards HSV-2 strain 333 and its glycoprotein C (gC)-truncated derivative HSV-2 gC-neg1 has been tested in monkey kidney cells. Our results indicate that the antiviral activity of bLf does not involve gC-HS interaction as there was no difference in its effectiveness towards wild type and mutant virus. As regards hLf, the mutant virus HSV-2 gC-neg1 was more sensitive compared to the wild type, suggesting that the human protein might interact with some viral structures that in wild-type viruses are masked by gC. When the modulation of HSV-2 infection by bLf and hLf was investigated under different experimental conditions, the bovine protein proved more effective than the human protein. Moreover, we found that, differently from what observed with HSV-1, bLf inhibited HSV-2 plaque-forming activity also in cells devoid of GAG expression. These results suggest that bLf may block a virus receptor of non-GAG nature and add new information on the anti-herpes virus activity of this protein, confirming it as an outstanding candidate for the treatment of herpetic infections.